Growing evidence also links neuroinflammation—driven by Aβ and tau accumulation—to AD progression, and the identification of AD risk genes linked to innate immunity implicates glial cells as key contributors to disease progression4, 5. This evidence concerns the gene MAPT and Alzheimer disease.